Subi Medicaments Private Limited

Subi Medicaments Private Limited - chemicals in Indore, Madhya Pradesh, India. Directors, charges & compliance details.
CIN U24239MP2020PTC053545 Incorporated 02 November 2020 ROC Gwalior HQ Indore, Madhya Pradesh, India
Struck Off Private Limited Company chemicals
Data last updated
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Company status
Struck Off
MCA master data
Registrar
Gwalior
ROC office
Incorporated
02 Nov 2020
Date of incorporation
Entity type
Private Limited
As registered with MCA

About Subi Medicaments Private Limited

Data last updated:

Subi Medicaments Private Limited was a private limited company based in Indore, Madhya Pradesh, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the speciality chemicals segment of the chemicals sector. It was incorporated on 02 November 2020.

The company was registered with the Registrar of Companies (ROC), Gwalior, under CIN U24239MP2020PTC053545.

The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Jyothi Vyas and Akshay Agrawal.

The registered office was at 63 Vaishno Vihar Schme No. 51, Indore, Madhya Pradesh, India – 452001.

Company Details of Subi Medicaments Private Limited
CIN U24239MP2020PTC053545
Registration Number 053545
Incorporation Date 02 November 2020
ROC Gwalior
Listing Status Unlisted
Company Status Struck Off
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    63 Vaishno Vihar Schme No. 51, Indore, Madhya Pradesh, India – 452001
  • Industry
    Chemicals, Other Chemical Product, Manufacturing
Comprehensive company report
Subi Medicaments Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Subi Medicaments Private Limited report

Financials, compliance, directors, charges, ownership and filings for Subi Medicaments Private Limited in one report.

Financials from FY 2021 Directors & ownership Charges & compliance

Financials of Subi Medicaments Private Limited

Premium access

Financial statements from FY 2021

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Subi Medicaments Private Limited

Subi Medicaments has 2 directors on record. No former directors are listed.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Jyothi VyasDirector02 Nov 20205 Years 11 MonthsAs last reported
Akshay AgrawalDirector02 Nov 20205 Years 11 MonthsAs last reported

Charges & Borrowings of Subi Medicaments Private Limited

Subi Medicaments Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Subi Medicaments Private Limited

Employment history and EPFO contributions of people linked to Subi Medicaments.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Subi Medicaments Private Limited

Subi Medicaments Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Akshay Agrawal was appointed as Director on 02 Nov 2020.

Appointed
Akshay Agrawal was appointed as Director.
Appointed
Jyothi Vyas was appointed as Director.
Incorporation
02 Nov 2020
Subi Medicaments Private Limited was registered on 02 Nov 2020 with Roc Gwalior & aged 5 years 11 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Subi Medicaments Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Subi Medicaments Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Subi Medicaments Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Subi Medicaments Private Limited

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Subi Medicaments Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subi Medicaments Private Limited

Subi Medicaments has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Subi Medicaments was a private limited company based in Indore, Madhya Pradesh, India. The company worked in other chemical product, within the chemicals industry. It was incorporated on 02 November 2020 and is registered under CIN U24239MP2020PTC053545. The company has been struck off by the Registrar of Companies and is no longer operational.

Subi Medicaments had 2 directors:

The CIN (Corporate Identification Number) of Subi Medicaments is U24239MP2020PTC053545. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Subi Medicaments is at 63 Vaishno Vihar Schme No. 51, Indore, Madhya Pradesh, India – 452001.

Subi Medicaments was incorporated on 02 November 2020. It is registered with the Registrar of Companies, Gwalior.

Subi Medicaments has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.

Subi Medicaments operated in the chemicals industry, in the other chemical product segment. It worked in this industry before it was struck off.

No. Subi Medicaments is not listed on any stock exchange. It is an unlisted company.

Akshay Agrawal was appointed as Director on 02 Nov 2020. Jyothi Vyas was appointed as Director on 02 Nov 2020.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available